Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Vogel

Showing results (821-830 of 859) with videos related to

Pageof 86
Sort By:
Biorxiv : the Preprint Server for Biology|December 18, 2023
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathologySophie E Mastenbroek, Jacob W Vogel, Lyduine E Collij, et al.
Nature Medicine|March 31, 2026
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementiaLijun An, Alexa Pichet Binette, Ines Hristovska, et al.
Nature Medicine|April 30, 2021
Four distinct trajectories of tau deposition identified in Alzheimer's diseaseJacob W Vogel, Alexandra L Young, Neil P Oxtoby, et al.
Cancer Research|April 12, 2013
Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosisThomas O'Hare, Christopher A Eide, Anupriya Agarwal, et al.
Nature Aging|March 22, 2024
Disease staging of Alzheimer's disease using a CSF-based biomarker modelGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 15, 2019
Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wardsL M Biehl, P Higgins, T Wille, et al.
Nature Communications|June 15, 2024
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathologySophie E Mastenbroek, Jacob W Vogel, Lyduine E Collij, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's diseaseGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Frontiers in Neurology|December 24, 2021
Distinctive Mediating Effects of Subcortical Structure Changes on the Relationships Between Amyloid or Vascular Changes and Cognitive DeclineNa-Yeon Jung, Jeong-Hyeon Shin, Hee Jin Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Generating synthetic tau-PET scans in Alzheimer's disease from MRI, blood biomarkers and demographics with deep learningLinda Karlsson, Olof Strandberg, Ruben Smith, et al.
Pageof 86

Showing results (821-830 of 859) with videos related to

Sort By:
Pageof 86
Biorxiv : the Preprint Server for Biology|December 18, 2023
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathologySophie E Mastenbroek, Jacob W Vogel, Lyduine E Collij, et al.
Nature Medicine|March 31, 2026
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementiaLijun An, Alexa Pichet Binette, Ines Hristovska, et al.
Nature Medicine|April 30, 2021
Four distinct trajectories of tau deposition identified in Alzheimer's diseaseJacob W Vogel, Alexandra L Young, Neil P Oxtoby, et al.
Cancer Research|April 12, 2013
Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosisThomas O'Hare, Christopher A Eide, Anupriya Agarwal, et al.
Nature Aging|March 22, 2024
Disease staging of Alzheimer's disease using a CSF-based biomarker modelGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 15, 2019
Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wardsL M Biehl, P Higgins, T Wille, et al.
Nature Communications|June 15, 2024
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathologySophie E Mastenbroek, Jacob W Vogel, Lyduine E Collij, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's diseaseGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Frontiers in Neurology|December 24, 2021
Distinctive Mediating Effects of Subcortical Structure Changes on the Relationships Between Amyloid or Vascular Changes and Cognitive DeclineNa-Yeon Jung, Jeong-Hyeon Shin, Hee Jin Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Generating synthetic tau-PET scans in Alzheimer's disease from MRI, blood biomarkers and demographics with deep learningLinda Karlsson, Olof Strandberg, Ruben Smith, et al.
Pageof 86